Nov 19, 2019
The Conference Forum Announces the Launch of Cell & Gene Therapy Day in NYC
Feb 12, 2019
Pioneering Physician-Scientist to Receive 2019 Szent-Györgyi Prize for Progress in Cancer Research
Jan 16, 2019
AIVITA Biomedical Receives IND Clearance for Phase 1B Melanoma Trial
Dec 18, 2018
OncoSec Announces Publication of New Research in the Journal Immunity Highlighting the Role of IL-12 in Anti-PD-1 Therapies with TAVO(TM) Directly Activating TILs in Patients
Dec 11, 2018
OncoSec Presents New Data Showing A Single Cycle Of Monotherapy TAVO(TM) Can Generate Productive Immune Responses In Triple Negative Breast Cancers (TNBC)
Dec 04, 2018
Phio Pharmaceuticals to Present at the Tumor Targeted Lymphocytes Summit in Boston on December 13
Nov 09, 2018
Nektar Therapeutics Presents New Clinical and Preclinical Data for its Immuno-Oncology Pipeline at the 2018 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Nov 07, 2018
OncoSec Doses First Patient in KEYNOTE-890 Phase 2 Clinical Trial
Oct 24, 2018
OncoSec Announces Publication of Data in Nature Gene Therapy Demonstrating the Ability of its Newly Optimized Intratumoral IL-12 Immunotherapy Platform to Increase Systemic Anti-tumor Responses in both Treated and Untreated Lesions
Oct 09, 2018
At the Forefront of Ovarian Cancer Treatment - Sheba Medical Center Offers TIL Trials
May 30, 2018
Syndax and Nektar Therapeutics Announce Immuno-Oncology Clinical Trial Collaboration
May 16, 2018
Lycera Announces Publication of Preclinical Immuno-Oncology Research, Demonstrating that Treatment with RORgamma Agonists Enhances CAR T-Cell Anti-Tumor Activity and Persistence, Resulting in Long-Lasting Anti-Tumor Memory T-Cells in an In Vivo Model
May 14, 2018
Surgeon Fueled by a Passion to Do More Launches SpeciCare to Preserve Live Tumor Tissue for Personalized Use in Cancer Care
Apr 16, 2018
RXi Pharmaceuticals Announces Publication in Molecular Therapy on Self-Delivering RNAi (sd-rxRNA®) Targeting PD-1 in Adoptive Cell Therapy for the Treatment of Malignant Melanoma
Jan 18, 2018
OncoSec Provides Encouraging Clinical Observations Related To Triple Negative Breast Cancer Study
Dec 01, 2017
RXi Pharmaceuticals and the Center for Cancer Immune Therapy at Herlev Hospital Announce Research Collaboration